STOCK TITAN

Anterix (ATEX) CEO sells 35,057 shares in August trade

(Very High)
(Negative)
Form Type
4

Rhea-AI Filing Summary

Anterix Inc. President and CEO Scott A. Lang reported open-market sales of 35,057 shares of Common Stock on August 14, 2026. The reported per-share prices include 800 shares at $91.69, plus additional blocks sold at weighted average prices that reflect multiple trades within specified price ranges.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Lang Scott A.
Role President and CEO
Sold 35,057 shs ($3.16M)
Type Security Shares Price Value
Sale Common Stock 800 $91.69 $73K
Sale Common Stock F1 10,087 $90.8697 $917K
Sale Common Stock F2 18,797 $90.1619 $1.69M
Sale Common Stock F3 5,373 $88.9645 $478K
Holdings After Transaction: Common Stock — 41,470 shares (Direct)
Footnotes (3)
  1. F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.62 to $90.665, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote to this Form 4.
  2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.66 to $89.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote to this Form 4.
  3. F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.515 to $88.525, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote to this Form 4.
Total shares sold 35,057 shares Aggregate non-derivative sales on August 14, 2026
Single-price sale block 800 shares at $91.6900 per share Non-derivative Common Stock sale on August 14, 2026
Weighted average price block 1 10,087 shares at $90.8697 per share Weighted average, trades from $91.62 to $90.665
Weighted average price block 2 18,797 shares at $90.1619 per share Weighted average, trades from $90.66 to $89.66
Weighted average price block 3 5,373 shares at $88.9645 per share Weighted average, trades from $89.515 to $88.525
Number of sale transactions 4 Non-derivative Common Stock sale entries reported
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
multiple transactions financial
"These shares were sold in multiple transactions at prices ranging from"
open market or private transaction financial
"Sale in open market or private transaction"

FAQ

What did ATEX President and CEO Scott A. Lang report in this Form 4?

Scott A. Lang reported selling 35,057 shares of Anterix Inc. Common Stock on August 14, 2026. The transactions were coded as open-market or private sales and reported as directly owned shares.

How many ATEX shares did Scott A. Lang sell and on what date?

Scott A. Lang sold 35,057 shares of Anterix Inc. Common Stock on August 14, 2026. The Form 4 transaction summary classifies all these as non-derivative sales of directly held shares.

At what prices were Scott A. Lang’s ATEX shares sold?

The reported sales include 800 shares at $91.69 per share. Other blocks were sold at weighted average prices, with underlying trades ranging from $91.62 to $88.525 per share across different price bands.

Were Scott A. Lang’s ATEX stock sales under a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is not marked as a plan transaction. Footnotes describe price ranges and weighted average prices but do not state that the sales were executed under a Rule 10b5-1 trading arrangement.

How many separate ATEX sale transactions did Scott A. Lang report?

Scott A. Lang reported four non-derivative sale transactions of Anterix Inc. Common Stock. One transaction reports a single per-share price, while three report weighted average prices over multiple trades within specified price ranges.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lang Scott A.

(Last)(First)(Middle)
3 GARRET MOUNTAIN PLAZA
SUITE 401

(Street)
WOODLAND PARK NEW JERSEY 07424

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Anterix Inc. [ ATEX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
President and CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/14/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/14/2026S800D$91.6975,727D
Common Stock08/14/2026S10,087D$90.8697(1)65,640D
Common Stock08/14/2026S18,797D$90.1619(2)46,843D
Common Stock08/14/2026S5,373D$88.9645(3)41,470D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.62 to $90.665, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote to this Form 4.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.66 to $89.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote to this Form 4.
3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.515 to $88.525, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote to this Form 4.
Remarks:
/s/ Gena L. Ashe08/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)